Send us Feedback

Takeda Pharmaceutical (TKPHF)
Analysis
SUMMARY
BULLS
BEARS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Dunsire out as Takeda rolls Millennium into its global R&D operations
FiercePharma  May 10  Comment 
CEO Deborah Dunsire is retiring from Millennium, the unit Takeda bought about 5 years ago, as Millennium's oncology R&D is rolled up into the parent company's global research organization.
UPDATED: Deborah Dunsire exits as Takeda cuts CEO role in Millennium shakeup
FierceBiotech  May 9  Comment 
Millennium CEO Deborah Dunsire is retiring and her business development chief Anna Protopapas will step in to head the oncology business of Takeda Pharmaceutical. The Japanese drugmaker revealed the management shakeup in a terse announcement today.
Japanese company Takeda acquires S'pore startup Inviragen for US$250m
Channel News Asia  May 8  Comment 
Singapore's push to develop a vaccine that prevents dengue infection has received a boost through a new partnership.
UPDATED: Takeda beefs up new vaccines arm with $250M bolt-on buyout of Inviragen
FierceBiotech  May 8  Comment 
A couple of months after moving its experimental dengue vaccine into the second phase of a mid-stage study, Fort Collins, CO-based Inviragen has been snapped up by Takeda in a $250 million deal.
Takeda to Acquire Inviragen for Upfront Payment of $35M
Benzinga  May 7  Comment 
Takeda Pharmaceutical Company Limited (OTC: TKPYY) and Inviragen, Inc. jointly announced today that Takeda, its wholly owned subsidiary Takeda America Holdings, Inc., and Inviragen, Inc. have entered into a definitive agreement for Takeda to...




more ▼WIKI ANALYSIS
 
TOP CONTRIBUTORS
Sr. Director
Isaac Middendorf

No more s***. All posts of this qaultiy from now on

Retrieved from "http://www.wikinvest.com/stock/Takeda_Pharmaceutical_(TKPHF)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki